References
1. Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys 1998. 252046–2053.
2. Warburg O, Wind F, Negleis E. On the metabolism of tumors in the body. The metabolism of tumours 1930. 254–270.
3. Mac Manus M, Hicks R, Ball D, Kalff V, Matthews J, McKenzie A, et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma : powerful correlation with survival and high impact on treatment. Cancer 2001. 92886–895.
4. Schoder H, Erdi YE, Larson SM, Yeung HW. PET/CT : a new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging 2003. 301419–1437.
5. Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat ("USA-Fat") : description on 18F-FDG PET/CT. J Nucl Med 2003. 44170–176.
6. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Steinert HC, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003. 3482500–2507.
7. Czernin J. Summary of Selected PET/CT Abstracts from the 2003 Society of Nuclear Medicine Annual Meeting. J Nucl Med 2004. 45S102–S103.
8. Ciernik IF, Dizendorf E, Baumert BG, Reiner B, Burger C, Von Schulthess GK, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT) : a feasibility study. Int J Radiat Oncol Biol Phys 2003. 57853–863.
9. Esthappan J, Mutic S, Malyapa RS, Grigsby PW, Zoberi I, Low DA, et al. Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes. Int J Radiat Oncol Biol Phys 2004. 581289–1297.
10. Schoder H, Larson SM, Yeung HW. PET/CT in oncology : integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med 2004. 45Suppl 1. S72–S81.
11. Cook GJ, Wegner EA, Fogelman I. Pitfalls and artifacts in FDG PET and PET/CT oncologic imaging. Semin Nucl Med 2004. 34122–133.
12. Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. J Nucl Med 2004. 45Suppl 1. S56–S65.
13. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and Neck Cancer : Clinical Usefulness and Accuracy of PET/CT Image Fusion. Radiology 2004. 23165–72.
14. Wahl RL. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med 2004. 45Suppl 1. S82–S95.
15. Ho C, Yu S, Yeung D. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 2003. 44213–221.
16. Shiomi S, Nishiguchi S, Ishizu H, Iwata Y, Sasaki N, Ochi H, et al. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am J Gastroenterol 2001. 961877–1880.
17. Torizuka T, Tamaki N, Inokuma T, Magata Y, Yonekura Y, Konishi J, et al. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 1994. 351965–1969.
18. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods(US, CT, MR imaging, PET) : a meta-analysis. Radiology 2002. 224748–756.
19. Donckier V, Van Laethem JL, Goldman S, Van Gansbeke D, Feron P, Gelin M, et al. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 2003. 84215–223.
20. Kato T, Tsukamoto E, Kuge Y, Katoh C, Nambu T, Tamaki N, et al. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging 2002. 291047–1054.
21. Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Berr F, et al. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 2001. 331029–1035.
22. Fritscher-Ravens A, Bohuslavizki KH, Broering DC, Jenicke L, Schafer H, Clausen M, et al. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 2001. 221277–1285.
23. Kim YJ, Yun M, Lee WJ, Kim KS, Lee JD. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 2003. 301467–1472.